We are fundamental long-term investors, often deploying our proprietary fund towards projects that have significant growth prospects or align with our long-term interests. We typically originate ideas within our team, research their viability and execute by partnering with wealth/early-stage investors who share the same vision. Early stage investors have the option to exit via institutional investors once the respective models have proved to be commercially viable. We are currently bullish on healthcare and financial technology (fintech) as a market disruptor.
